Nifurtimox is an antiparasitic medication primarily used to treat Chagas disease, caused by the Trypanosoma cruzi parasite. It matters in clinical practice as it can significantly reduce morbidity and mortality associated with chronic Chagas disease, especially in acute cases or in children. A key association is its potential side effects, including gastrointestinal disturbances and neuropsychiatric symptoms, which may affect patient adherence to treatment.
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.